Trials / Completed
CompletedNCT03626519
Effects of Menthol on Dyspnoea in COPD Patients
Effects of Menthol on Dyspnoea Induced by Exercise in COPD Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Groupe Hospitalier du Havre · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chronic obstructive pulmonary disease (COPD) is characterised by non-reversible bronchial obstruction associated with systemic disorders and comorbid factors. Dyspnoea is a common symptom among patients with Chronic Obstructive pulmonary Disease (COPD). Dyspnea is the primary symptom limiting exercise and daily activities in these patients. It has been reported that breathing cold air could decrease dyspnoea induced by exercise and could improve exercise performance. The aim of this study is to carry out the effect of cooling sensation induced by menthol chewing-gum on dyspnoea and exercise performance among patients with COPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Test with Menthol | patients will perform a Six-minute walk test according to American Thoracic Society guidelines |
| OTHER | Test with placebo | patients will perform a Six-minute walk test according to American Thoracic Society guidelines |
Timeline
- Start date
- 2019-09-23
- Primary completion
- 2021-03-12
- Completion
- 2021-03-12
- First posted
- 2018-08-13
- Last updated
- 2021-04-23
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03626519. Inclusion in this directory is not an endorsement.